Skip to Content

Recombinant Zoster Vaccine (Shingrix)

Last Updated: April 16, 2020
Status: Current

Products Affected - Description
    • Shingrix, GlaxoSmithKline, 0.5 mL vial, 1 count, NDC 58160-0819-12
    • Shingrix, GlaxoSmithKline, 0.5 mL vial, 10 count, NDC 58160-0823-11
Reason for the Shortage
    • GlaxoSmithKline has Shingrix on shortage due to high demand for the product.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • GlaxoSmithKline has Shingrix on allocation with regular releases.


Updated April 16, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 17, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.